This article will discuss potential clinical strategies for adding a GLP-1 RA to basal insulin, using demonstrative case studies to illustrate circumstances in which a patient may benefit from this...
The FDA has issued a warning based on 20 reported cases of ketoacidosis in patients using sodium-glucose co-transporter 2 inhibitors for type 2 diabetes.